3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
NIH
3
OTHER
2
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Cyclophosphamide
39
Docetaxel
30
Tamoxifen
29
Paclitaxel
27
Doxorubicin
26
Trastuzumab
20
Radiotherapy
18
Epirubicin
16
Letrozole
13
exemestane
11
Fluorouracil
11
Anastrozole
11
Capecitabine
10
Bevacizumab
10
Immunohistochemistry
9
Filgrastim
9
Fulvestrant
8
Methotrexate
7
Gene Expression Profiling
7
palbociclib
6
Zoledronic Acid
6
Microarray Analysis
6
Lapatinib
6
Goserelin
6
Chemotherapy, Adjuvant
6
Amplified Fragment Length Polymorphism Analysis
6
Vinorelbine
5
Triptorelin Pamoate
5
Carboplatin
5
Absorptiometry, Photon
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms
×
Ovariectomy
×
Clear all
NCT00066690
2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
3,066 enrolled
15 charts
NCT00066807
2016-10-28
PERCHE
ETOP IBCSG Partners Foundation
Phase 3
Terminated
29 enrolled
6 charts